Allogeneic Peripheral Blood Progenitor Cells: Current Status and Future Directions
- 1 August 1996
- journal article
- review article
- Published by Mary Ann Liebert Inc in Journal of Hematotherapy
- Vol. 5 (4) , 331-337
- https://doi.org/10.1089/scd.1.1996.5.331
Abstract
Increasing use is being made of mobilized peripheral blood as a source of hematopoietic stem and progenitor cells for transplantation. Initially, these efforts were focused on autologous applications. However, many centers are now using cells derived from normal donors mobilized with recombinant hematopoietic growth factors for allogeneic transplantation. This article reviews the key issues associated with the use of these cells for hematologic reconstitution and summarizes important recent developments in the field.Keywords
This publication has 44 references indexed in Scilit:
- Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patientsThe Lancet, 1996
- G-CSF-Induced Mobilization of Peripheral Blood Stem Cells from Healthy Adults for Allogeneic TransplantationJournal of Hematotherapy, 1996
- Haematological study of healthy volunteers 5 years after G-CSFThe Lancet, 1995
- Case Report Successful Engraftment Using Allogeneic Peripheral Blood Progenitor Cells in a Patient with Primary Bone Marrow Graft FailureJournal of Hematotherapy, 1995
- Transplantation of allogeneic peripheral blood stem cellsThe International Journal of Cell Cloning, 1995
- G‐CSF‐mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graftBritish Journal of Haematology, 1994
- Characterization of Peripheral Blood Progenitor Cells Mobilized by Cytotoxic Chemotherapy and Recombinant Human Granulocyte Colony-Stimulating FactorJournal of Hematotherapy, 1994
- Peripheral blood stem cells as an alternative to marrow for allogeneic transplantationThe Lancet, 1993
- Haemopoietic cells mobilised into the circulation by lenograstim as alternative to bone marrow for allogeneic transplantsThe Lancet, 1993
- Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapyThe Lancet, 1992